LXRX 8-K 2026-08-06

LEXICON PHARMACEUTICALS, INC. (LXRX) 8-K dated 2026-08-06 — accession 0001062822-26-000112. This URL is the filing, not the LXRX hub.

LEXICON PHARMACEUTICALS, INC. (LXRX) is a biotechnology company listed on US.

LEXICON PHARMACEUTICALS, INC. filed a 8-K on 2026-08-06. Accession 0001062822-26-000112.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported LXRX revenue for 2025-12-31 was $49.8M. Net income was -$50.3M. Revenue was up 60.2% from 2024-12-31 to 2025-12-31. LXRX currently screens at market cap $327.2M.

Not investment advice. The LXRX SEC hub lists recent forms. The stock page is the research view.